AU2003263161A8 - Method for making recombinant proteins - Google Patents

Method for making recombinant proteins

Info

Publication number
AU2003263161A8
AU2003263161A8 AU2003263161A AU2003263161A AU2003263161A8 AU 2003263161 A8 AU2003263161 A8 AU 2003263161A8 AU 2003263161 A AU2003263161 A AU 2003263161A AU 2003263161 A AU2003263161 A AU 2003263161A AU 2003263161 A8 AU2003263161 A8 AU 2003263161A8
Authority
AU
Australia
Prior art keywords
recombinant proteins
making recombinant
making
proteins
recombinant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003263161A
Other versions
AU2003263161A1 (en
Inventor
Anette Amstrup Pedersen
Ruth Buemann Simesen
Dietmar Weilguny
Jan Eric Jensen
Steffen Faisst
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU2003263161A1 publication Critical patent/AU2003263161A1/en
Publication of AU2003263161A8 publication Critical patent/AU2003263161A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6437—Coagulation factor VIIa (3.4.21.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21021—Coagulation factor VIIa (3.4.21.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/46—Vector systems having a special element relevant for transcription elements influencing chromatin structure, e.g. scaffold/matrix attachment region, methylation free island
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
AU2003263161A 2002-09-20 2003-09-19 Method for making recombinant proteins Abandoned AU2003263161A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DKPA200201384 2002-09-20
DKPA200201384 2002-09-20
US41656602P 2002-10-07 2002-10-07
US60/416,566 2002-10-07
PCT/DK2003/000607 WO2004027072A2 (en) 2002-09-20 2003-09-19 Method for making recombinant proteins

Publications (2)

Publication Number Publication Date
AU2003263161A1 AU2003263161A1 (en) 2004-04-08
AU2003263161A8 true AU2003263161A8 (en) 2004-04-08

Family

ID=32031674

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003263161A Abandoned AU2003263161A1 (en) 2002-09-20 2003-09-19 Method for making recombinant proteins

Country Status (3)

Country Link
EP (1) EP1554389A2 (en)
AU (1) AU2003263161A1 (en)
WO (1) WO2004027072A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60312039T2 (en) 2002-12-20 2007-11-08 Chromagenics B.V. MEANS AND METHODS FOR THE PRODUCTION OF A PROTEIN BY CHROMATIN OPENERS WHICH MAY MAKE CHROMATIN ACCESSIBLE TO TRANSCRIPTION FACTORS
US8999667B2 (en) 2004-11-08 2015-04-07 Chromagenics B.V. Selection of host cells expressing protein at high levels
US8039230B2 (en) 2004-11-08 2011-10-18 Chromagenics B.V. Selection of host cells expressing protein at high levels
US20060195935A1 (en) 2004-11-08 2006-08-31 Chromagenics B.V. Selection of host cells expressing protein at high levels
KR101271884B1 (en) 2004-11-08 2013-06-05 크로마제닉스 비.브이. Selection of host cells expressing protein at high levels
US7968700B2 (en) 2006-03-20 2011-06-28 Chromagenics B.V. Expression augmenting DNA fragments, use thereof, and methods for finding thereof
EP3382029B1 (en) * 2017-03-31 2021-12-08 Toto Ltd. Recombinant mammalian cells and method for producing substance of interest

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888774A (en) * 1994-12-19 1999-03-30 Cangene Corporation Recombinant DNA molecules and expression vectors for erythropoietin
DE19848017A1 (en) * 1998-10-17 2000-04-20 Multigene Biotech Gmbh Episomally replicating vectors, useful in gene therapy, contain origins of replication and scaffold-matrix attached region sequences but no viral coding sequences
KR100408844B1 (en) * 2000-07-29 2003-12-06 한국산업기술평가원 Expression vector using for animal cell

Also Published As

Publication number Publication date
WO2004027072A3 (en) 2004-05-13
AU2003263161A1 (en) 2004-04-08
WO2004027072A2 (en) 2004-04-01
EP1554389A2 (en) 2005-07-20

Similar Documents

Publication Publication Date Title
PL376821A1 (en) Methods for increasing polypeptide production
AU2003239365A8 (en) Recombinant glycosyltransferase fusion proteins
EP1499352A4 (en) Recombinant anti-interleukin-9 antibodies
AU2003210137A8 (en) Method for producing recombinant proteins in micro-organisms
GB0208331D0 (en) Proteins
GB0209884D0 (en) Proteins
AU2003283174A8 (en) Method for protein production
IL162780A0 (en) Method for producing modified peptide
GB0220770D0 (en) Proteins
AU2003263161A8 (en) Method for making recombinant proteins
EP1487874A4 (en) Falp proteins
GB0200689D0 (en) Fusion proteins
GB0212067D0 (en) Proteins
IL169260A0 (en) Il-8 -like proteins
AU2003270055A8 (en) Neurotransmission-associated proteins
GB0123858D0 (en) Method for analysing protein/peptide expression
AU2003300785A8 (en) Carbohydrate-associated proteins
PL377523A1 (en) Method for preparing recombinant heterocarpine
AU2003295760A8 (en) Organelle-associated proteins
AU2003236908A8 (en) Proteins
GB0216757D0 (en) Proteins
GB0221470D0 (en) Protein fractionation methods for proteomics
GB0209013D0 (en) Recombinant protein expression
GB0225568D0 (en) Recombinant protein expression
GB0200250D0 (en) Recombinant protein expression

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase